Aetna to acquire Medicity for $500M

Mary Stevens | | Health Exec | Informatics
Aetna has entered into an agreement to acquire Medicity, a health information exchange (HIE) technology company, for approximately $500 million.

Medicity offers products and services that enable health systems, hospitals, physician practices and HIEs to access and exchange healthcare information. The Salt Lake City-based company markets its products and services nationwide.

Medicity’s HIE technology is used in more than 760 hospitals, by 125,000 physicians and 250,000 end users. Medicity’s technology platform, combined with Aetna resources, will allow development of new business offerings, according to Aetna, a Hartford, Conn.-based insurance provider.

Medicity will operate as a separate business within Aetna, under its existing leadership structure.

The transaction is subject to customary closing conditions, including Hart-Scott-Rodino antitrust regulatory approval, and is projected to be neutral to Aetna’s financial results in 2011, Aetna stated.

 

Mary Stevens

Related Content

Alabama security breach exposes personal information of cardiologists, heart patients
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Best in KLAS 2024: New rankings for cardiovascular information systems, hemodynamic solutions
Best in KLAS 2024 rankings released, showcasing medical imaging IT systems
Cloud image storage for radiology is a growing trend in healthcare
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.